Lv51
910 积分 2024-01-30 加入
Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies
2天前
已完结
The Time Toxicity of Cancer Treatment
3天前
已关闭
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4
4天前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4天前
已完结
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
4天前
已完结
Satisfaction With Current Migraine Therapy: Experience From 3 Centers in US and Sweden
5天前
已完结
Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
5天前
已完结
Association between migraine and risk of stroke: a systematic review and meta-analysis
7天前
已完结
Cyclin‐dependent kinase 4/6 inhibitors and cardiotoxic events in breast cancer: A pharmacovigilance study based on the FAERS database
9天前
已完结
Breast cancer in China
12天前
已完结
皖公网安备34019202002308
